Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab to treat adults with bullous pemphigoid.

Bristol Myers said about 5% to 7% of people with metastatic colorectal cancer have microsatellite instability-high or mismatch-repair-deficient tumors, adding that these patients are less likely to ...

Morgantown’s Civilian Police Review and Advisory Board has set a review of the Morgantown Police Department’s officer-worn ...

Minister for Social Security and Disabilities, Sir Stephen Timms also reassured existing PIP claimants with an outstanding ...

Neuren Pharmaceuticals was among the best-performing ASX 200 stocks in morning trade after securing a rare pediatric disease ...

RBI raises loan limits for urban cooperative banks, adjusts real estate exposure norms, and extends deadline for prudential ...

Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced that the U.S. Food and Drug ...

Pakistan Banks Association (PBA) Chairman Zafar Masood said on Monday that the Federal Board of Revenue (FBR) should not push ...

Senate bills 12 and 1565 would withhold funding from Texas public schools that don’t comply with the state’s DEI ban.

Higher education institutions are investing in sustainability initiatives, but their specific goals and challenges remain ...